Literature DB >> 20136414

A piglet model of acute gastroenteritis induced by Shigella dysenteriae Type 1.

Kwang-Il Jeong1, Quanshun Zhang, John Nunnari, Saul Tzipori.   

Abstract

BACKGROUND: The lack of a standardized laboratory animal model that mimics key aspects of human shigellosis remains a major obstacle to addressing questions about pathogenesis, screening therapeutics, and evaluation of vaccines.
METHODS: We characterized a piglet model for Shigella dysenteriae type 1.
RESULTS: Piglets developed acute diarrhea, anorexia, and dehydration, which could often be fatal, with symptom severity depending on age and dose. Bacteria were apparent in the lumen and on the surface epithelium throughout the gut initially, but severe mucosal damage and bacterial cellular invasion were most profound in the colon. Detached necrotic colonocytes were present in the lumen, with inflammatory cells outpouring from damaged mucosa. High levels of interleukin (IL)-8 and IL-12 were followed by high levels of other proinflammatory cytokines. Elevated levels of tumor necrosis factor-alpha, IL-1beta, IL-6, and IL-10 were detected in feces and in gut segments from infected animals. Bacteria were present inside epithelial cells and within colonic lamina propria. In contrast, an isogenic strain lacking Shiga toxin induced similar but milder symptoms, with moderate mucosal damage and lower cytokine levels.
CONCLUSION: We conclude that piglets are highly susceptible to shigellosis, providing a useful tool with which to compare vaccine candidates for immunogenicity, reactogenicity, and response to challenge; investigate the role of virulence factors; and test the efficacy of microbial agents.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20136414      PMCID: PMC2826551          DOI: 10.1086/650995

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  An outbreak of dysentery caused by Shigella dysenteriae type 1 on a coral island in the Bay of Bengal.

Authors:  M M Rahaman; M M Khan; K M Aziz; M S Islam; A K Kibriya
Journal:  J Infect Dis       Date:  1975-07       Impact factor: 5.226

2.  Failure of parenteral vaccines to protect monkeys against experimental shigellosis.

Authors:  S B Formal; R M Maenza; S Austin; E H LaBrec
Journal:  Proc Soc Exp Biol Med       Date:  1967-06

3.  Shigella infection in a SCID mouse-human intestinal xenograft model: role for neutrophils in containing bacterial dissemination in human intestine.

Authors:  Z Zhang; L Jin; G Champion; K B Seydel; S L Stanley
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohemorrhagic Escherichia coli infection.

Authors:  S Tzipori; F Gunzer; M S Donnenberg; L de Montigny; J B Kaper; A Donohue-Rolfe
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

5.  Persistence of local cytokine production in shigellosis in acute and convalescent stages.

Authors:  R Raqib; A A Lindberg; B Wretlind; P K Bardhan; U Andersson; J Andersson
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

6.  Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.

Authors:  Justen H Passwell; Shai Ashkenazi; Efrat Harlev; Dan Miron; Reut Ramon; Nahid Farzam; Liat Lerner-Geva; Yonit Levi; Chiayung Chu; Joseph Shiloach; John B Robbins; Rachel Schneerson
Journal:  Pediatr Infect Dis J       Date:  2003-08       Impact factor: 2.129

7.  Protection of monkeys against experimental shigellosis with a living attenuated oral polyvalent dysentery vaccine.

Authors:  S B Formal; T H Kent; H C May; A Palmer; S Falkow; E H LaBrec
Journal:  J Bacteriol       Date:  1966-07       Impact factor: 3.490

8.  The Shigella dysenteriae serotype 1 proteome, profiled in the host intestinal environment, reveals major metabolic modifications and increased expression of invasive proteins.

Authors:  Rembert Pieper; Quanshun Zhang; Prashanth P Parmar; Shih-Ting Huang; David J Clark; Hamid Alami; Arthur Donohue-Rolfe; Robert D Fleischmann; Scott N Peterson; Saul Tzipori
Journal:  Proteomics       Date:  2009-11       Impact factor: 3.984

9.  Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.

Authors:  S B Formal; E V Oaks; R E Olsen; M Wingfield-Eggleston; P J Snoy; J P Cogan
Journal:  J Infect Dis       Date:  1991-09       Impact factor: 5.226

10.  Epidemic Shiga bacillus dysentery in Central Africa.

Authors:  J R Ebright; E C Moore; W R Sanborn; D Schaberg; J Kyle; K Ishida
Journal:  Am J Trop Med Hyg       Date:  1984-11       Impact factor: 2.345

View more
  15 in total

Review 1.  Shiga toxins expressed by human pathogenic bacteria induce immune responses in host cells.

Authors:  Moo-Seung Lee; Myung Hee Kim; Vernon L Tesh
Journal:  J Microbiol       Date:  2013-12-19       Impact factor: 3.422

Review 2.  Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology.

Authors:  Maite Muniesa; Jens A Hammerl; Stefan Hertwig; Bernd Appel; Harald Brüssow
Journal:  Appl Environ Microbiol       Date:  2012-04-13       Impact factor: 4.792

3.  An Experimental Adult Zebrafish Model for Shigella Pathogenesis, Transmission, and Vaccine Efficacy Studies.

Authors:  Debaki R Howlader; Ushasi Bhaumik; Prolay Halder; Aishwarya Satpathy; Sounak Sarkar; Mrinalini Ghoshal; Suhrid Maiti; Jeffrey H Withey; Jiro Mitobe; Shanta Dutta; Hemanta Koley
Journal:  Microbiol Spectr       Date:  2022-05-23

4.  Human Intestinal Enteroids as a Model System of Shigella Pathogenesis.

Authors:  Benjamin J Koestler; Cara M Ward; C R Fisher; Anubama Rajan; Anthony W Maresso; Shelley M Payne
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

5.  A pig model of the human gastrointestinal tract.

Authors:  Quanshun Zhang; Giovanni Widmer; Saul Tzipori
Journal:  Gut Microbes       Date:  2013-04-02

6.  In vivo versus in vitro protein abundance analysis of Shigella dysenteriae type 1 reveals changes in the expression of proteins involved in virulence, stress and energy metabolism.

Authors:  Srilatha Kuntumalla; Quanshun Zhang; John C Braisted; Robert D Fleischmann; Scott N Peterson; Arthur Donohue-Rolfe; Saul Tzipori; Rembert Pieper
Journal:  BMC Microbiol       Date:  2011-06-24       Impact factor: 3.605

7.  Effect of wild-type Shigella species and attenuated Shigella vaccine candidates on small intestinal barrier function, antigen trafficking, and cytokine release.

Authors:  Maria Fiorentino; Myron M Levine; Marcelo B Sztein; Alessio Fasano
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

8.  Impact of dynasore an inhibitor of dynamin II on Shigella flexneri infection.

Authors:  Mabel Lum; Stephen R Attridge; Renato Morona
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

9.  Pathogenicity of Shigella in chickens.

Authors:  Run Shi; Xia Yang; Lu Chen; Hong-tao Chang; Hong-ying Liu; Jun Zhao; Xin-wei Wang; Chuan-qing Wang
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

10.  The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominis.

Authors:  Sangun Lee; Melanie Harwood; Don Girouard; Marvin J Meyers; Mary A Campbell; Gillian Beamer; Saul Tzipori
Journal:  PLoS One       Date:  2017-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.